Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Corista DP3® Platform Receives Class II Medical Device License From Health Canada


DP3's momentum as a world-class integrated pathology solution grows

CONCORD, Mass., Feb. 7, 2024 /PRNewswire-PRWeb/ -- Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License from Health Canada for its DP3 platform.

"We've been building a world-class solution for integrated pathology. Attaining the Class II Medical Device License from Canada is an important milestone in making this possible," says Corista CEO and Co-Founder Elizabeth Wingard.

DP3 is a web-based image management platform designed to provide pathologists with the essential tools to better manage patient cases and to more easily share, collaborate and analyze digital whole-slide images for routine pathology use. It streamlines the diagnostic process by increasing workflow efficiencies and consultations within and between healthcare organizations and remote locations, expediting patient results and improving the quality of patient care.

The Class II Medical Device License further supports Corista's recently announced strategic partnership with AGFA HealthCare, providing a digital pathology workflow solution to its Canadian customer base. It also comes on the heels of the recent CE Mark Corista earned under In Vitro Diagnostic Regulations (IVDR) marking for routine diagnosis in the European Union and the United Kingdom. Like the Class II Medical Device License, the CE Mark affirms that DP3 is a reliable and responsible product for use in the European Economic Area (EEA) and complies with European and UK regulations.

"We've been building a world-class solution for integrated pathology," says Corista CEO and Co-Founder Elizabeth Wingard. "Attaining the Class II Medical Device License from Canada is an important milestone in making this possible. We are looking forward to working with friends and colleagues as we bring Corista's capabilities and impact to Canada."

To learn more about Corista and the DP3 Image Management System for digital pathology, please visit www.corista.com.

About Corista

Corista is recognized for its innovations in digital pathology, providing solutions that enhance diagnostic and operational efficiency. The DP3 platform equips pathologists with essential tools for managing diagnostic workflows and facilitating consultations within and between healthcare organizations.

Media Contact

Anne Marsden, Marsden Marketing, 1 678-369-0073, anne@marsdenmarketing.com, www.marsdenmarketing.com

SOURCE Corista


These press releases may also interest you

at 02:05
Trinasolar and Universidad Politécnica de Madrid join forces on solar technologies research
Trinasolar has announced the signing of a long-term collaboration agreement with the Institute of Solar Energy at Universidad Politécnica de Madrid (IES-UPM). The agreement, signed on June 26, is a milestone in Trinasolar's involvement with leading...

at 02:00
Dawn Health and Merck are collaborating to support Growth Disorders care
Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, Merck, on a digital solution for Growth Hormone Disorders (GHD). Over the next two years, they...

at 02:00
Africa Energy Announces Block 11B/12B Operations Update
Africa Energy Corp. ("Africa Energy" or the "Company") announces that CNR International (South Africa) Limited ("CNR") has provided notice to the joint venture partners that it will withdraw from its 20% interest in accordance with the joint...

at 01:33
Global Times: CPC members reach 99.185 million
The 103-year-old Communist Party of China (CPC) demonstrates strong resilience as a flourishing organization, with the number of CPC members reaching 99.185 million, the latest data showed on Sunday, a day ahead of the CPC's 103rd founding...

at 01:00
Gunvor and Quercus announce landmark solar development partnership in Italy
Gunvor Group ("Gunvor"), a leading global energy commodities trading company, together with Quercus Real Assets Limited ("Quercus"), the London-based renewable specialist focused on international investments within the Energy Transition, proudly...

at 00:05
Spirit AeroSystems Announces Acquisition by Boeing in $8.3 Billion Transaction
Spirit AeroSystems [NYSE: SPR] ("Spirit") today announced it has entered into a definitive merger agreement under which The Boeing Company [NYSE: BA] ("Boeing") will acquire Spirit for $37.25 per share in Boeing common stock (subject to the collar...

More news about Business...


News published on and distributed by: